Gene · 1213
NIH grants2,119
NIH grants whose papers are about the gene, through NIH's grant-paper links.
421 to 440 of 2,119
Download this page as JSON| Grant | Title | CLTC papers | Newest fiscal year |
|---|---|---|---|
| R01AG068168 | Extracellular Vesicle treatment and age-related neuropathology in non-human primates | 1 | 2024 |
| R01AI118426 | Molecular Basis of Human Toxoplasmosis | 1 | 2024 |
| R01AI120691 | Allostery and Hijacking of Host Membrane Traffic by HIV-1 Accessory Proteins | 1 | 2024 |
| R01AI148342 | VENOUS: A translational study of enterococcal bacteremia | 1 | 2024 |
| R01AI150701 | The Staphylococcus aureus response to nutrient zinc restriction during infection | 1 | 2024 |
| R01AI150869 | Role of immune modulating butyrophilins in gamma delta T cell activation | 1 | 2024 |
| R01AI157802 | Ultra-potent HIV capsid inhibitors | 1 | 2024 |
| R01AR057352 | Characterization of the Insulin to Autophagy Pathway in Muscles | 1 | 2024 |
| R01CA138804 | Role of PALB2 in the DNA Damage Response and Cancer Suppression | 1 | 2024 |
| R01CA154475 | NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA | 1 | 2024 |
| R01CA237332 | Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) | 1 | 2024 |
| R01CA242845 | Blocking tumor progression in therapy-responsive RET aberration-associated cancer | 1 | 2024 |
| R01CA248304 | Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer | 1 | 2024 |
| R01DK126887 | Mechanisms of lipid droplet organization and functional diversification | 1 | 2024 |
| R01GM051586 | Protein phosphorylation and growth factor function | 1 | 2024 |
| R01GM077349 | Dynamics of Endomembrane Docking and Fusion | 1 | 2024 |
| R01GM139823 | How flaviviruses hijack a host transmembrane protein chaperone to promote viral infection | 1 | 2024 |
| R01HL105756 | CHARGE consortium: omics discovery for CVD and aging phenotypes | 1 | 2024 |
| R01HL164835 | Individualized Prediction of Treatment Effects Using Data from Both Embedded Clinical Trials and Electronic Health Records | 1 | 2024 |
| R01NS028829 | Electrical Stimulation of Immediate Early Genes | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1213/grants?page=22